Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.

Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB.

Radiology. 1994 May;191(2):371-7.

PMID:
8153308
2.

Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer.

Bury T, Paulus P, Dowlati A, Corhay JL, Weber T, Ghaye B, Schoffers J, Limet R, Albert A, Rigo P, Radermecker M.

Eur Respir J. 1996 Dec;9(12):2560-4.

3.

The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography.

Sasaki M, Ichiya Y, Kuwabara Y, Akashi Y, Yoshida T, Fukumura T, Murayama S, Ishida T, Sugio K, Masuda K.

Eur J Nucl Med. 1996 Jul;23(7):741-7.

PMID:
8662111
4.

Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).

Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN.

Thorax. 1997 May;52(5):438-41.

5.

Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.

Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, von Schulthess GK, Weder W.

Radiology. 1997 Feb;202(2):441-6.

PMID:
9015071
6.

[Positron emission tomography in the evaluation of intrathoracic lymphatic extension of non-small cell bronchial cancer. A preliminary study of 30 patients].

Bury T, Corhay JL, Paulus P, Weber T, D'Harcour JB, Limet R, Rigo P, Radermecker MF.

Rev Mal Respir. 1996 Jul;13(3):281-6. French.

PMID:
8765921
7.

Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.

Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verschakelen JA, Nackaerts KL, Mortelmans LA.

Chest. 1997 Dec;112(6):1480-6.

PMID:
9404742
8.

Mediastinal staging of non-small-cell lung cancer with positron emission tomography.

Chin R Jr, Ward R, Keyes JW, Choplin RH, Reed JC, Wallenhaupt S, Hudspeth AS, Haponik EF.

Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2090-6.

PMID:
8520780
9.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.

PMID:
14644890
10.

Detection of scalene lymph node metastases from lung cancer. Positron emission tomography.

Scott WJ, Gobar LS, Hauser LG, Sunderland JJ, Dewan NA, Sugimoto JT.

Chest. 1995 Apr;107(4):1174-6. Erratum in: Chest 1995 Jun;107(6):1776.

PMID:
7705136
11.

Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration.

Aquino SL, Asmuth JC, Alpert NM, Halpern EF, Fischman AJ.

J Comput Assist Tomogr. 2003 Jul-Aug;27(4):479-84.

PMID:
12886128
12.

Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.

Sazon DA, Santiago SM, Soo Hoo GW, Khonsary A, Brown C, Mandelkern M, Blahd W, Williams AJ.

Am J Respir Crit Care Med. 1996 Jan;153(1):417-21.

PMID:
8542152
14.

FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group.

Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, De Wever WF, Verbeken EK, Nuyts JL, Maes FP, Bogaert JG.

Eur J Nucl Med. 1998 Nov;25(11):1495-501.

PMID:
9799345
16.

Preoperative staging of non-small-cell lung cancer with positron-emission tomography.

Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koëter GH, Fidler V, Pruim J, Groen HJ.

N Engl J Med. 2000 Jul 27;343(4):254-61.

17.

F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.

Berlangieri SU, Scott AM, Knight SR, Fitt GJ, Hennessy OF, Tochon-Danguy HJ, Clarke CP, McKay WJ.

Eur J Cardiothorac Surg. 1999 Sep;16 Suppl 1:S25-30.

PMID:
10536941
18.

[PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer].

Weber WA, Dietlein M, Hellwig D, Kirsch CM, Schicha H, Schwaiger M.

Nuklearmedizin. 2003 Aug;42(4):135-44. German.

PMID:
12937692
19.

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.

Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Review.

PMID:
19464906
20.

Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.

Patz EF Jr, Lowe VJ, Goodman PC, Herndon J.

Chest. 1995 Dec;108(6):1617-21.

PMID:
7497771

Supplemental Content

Support Center